A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

Fact checked by Nick Blackmer Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

Wegovy is a form of semaglutide indicated specifically for weight loss. One group of insured individuals who may not be able to access it are Medicare ... The cost of compounded versions of ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.

Novo Nordisk, the manufacturer of Weggovy, is growing its offerings by creating NovoCare Pharmacy, a direct-to-patient (DTP) ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...